Growth Metrics

Ultragenyx Pharmaceutical (RARE) Profit After Tax Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 65.80%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -290.15%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 59.59%
7 Evaxion A 62.56 Bn 62.54 Bn - -129.68%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,228.66%
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn -22.52%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -22.52%
Dec 31, 2025 3.49%
Sep 30, 2025 -35.12%
Jun 30, 2025 12.65%
Mar 31, 2025 11.53%
Dec 31, 2024 -7.81%
Sep 30, 2024 16.37%
Jun 30, 2024 17.66%
Mar 31, 2024 -4.09%
Dec 31, 2023 18.63%
Sep 30, 2023 34.87%
Jun 30, 2023 -1.05%
Mar 31, 2023 -7.65%
Dec 31, 2022 -23.99%
Sep 30, 2022 -235.77%
Jun 30, 2022 -29.19%
Mar 31, 2022 -11.88%
Dec 31, 2021 -410.01%
Sep 30, 2021 -6.03%
Jun 30, 2021 -583.62%
Mar 31, 2021 -14.38%
Dec 31, 2020 74.40%
Sep 30, 2020 39.07%
Jun 30, 2020 125.53%
Mar 31, 2020 -23.02%
Dec 31, 2019 -6.81%
Sep 30, 2019 -29.42%
Jun 30, 2019 -88.08%
Mar 31, 2019 -419.82%
Dec 31, 2018 -1,271.01%
Sep 30, 2018 -10.20%
Jun 30, 2018 27.66%
Mar 31, 2018 144.30%
Dec 31, 2017 110.52%
Sep 30, 2017 -22.06%
Jun 30, 2017 -28.05%
Mar 31, 2017 -29.44%
Dec 31, 2016 -29.10%
Sep 30, 2016 -65.44%
Jun 30, 2016 -91.10%
Mar 31, 2016 -146.77%
Dec 31, 2015 -229.91%
Sep 30, 2015 -147.54%
Jun 30, 2015 -119.26%
Mar 31, 2015 -56.85%
Dec 31, 2014 -47.90%
Sep 30, 2014 -88.05%
Jun 30, 2014 -58.15%
Mar 31, 2014 -102.38%